DUODART caps 0.5mg/0.4mg bte 7 pce
7680600950078
CH-60095
G04CA52
05.99.0.
1 / 3
google
Details
- Product number
- 6009501
- CPT
- -
- Packaging group
- 7
- Unit
- Kapsel(n)
- Composition
- dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, Dutasterid-Weichkapsel innerhalb der Hartkapsel: glyceroli mono/dioctanoas/decanoas, E 321, gelatina, glycerolum, E 171, E 172, aqua purificata, triglycerida media, lecithinum ex soja, Tamsulosin-Pellets in Hartkapsel: cellulosum microcristallinum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum polysorbatum 80 et natrii laurilsulfas, talcum, triethylis citras, aqua purificata, Kapselhülle: carrageenanum, kalii chloridum, aqua purificata, hypromellosum, cera carnauba, maydis amylum, E 110 0.04-0.08 mg, E 171, E 172, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 245 µg.
Articles (1)
Duodart, Kapseln
Kapseln
7
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.4 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.367 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
245.0 UG | Substance | HBESI |
Reimbursement information
Public price
CHF 17.05
Specialties list
Yes
Generic
No
SL addition date:
01/02/2012
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 60095
- Drug name
- Duodart, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- G04CA52
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 17/03/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 05.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DUODART caps 0.5mg/0.4mg bte 7 pce
- Description (DE)
- DUODART Kaps 0.5mg/0.4mg Ds 7 Stk
- Market launch
- 17/03/2010
- Narcotic (BTM)
- No